Delivery Order SPE2DB24D1205-SPE2DB25FCXGT
- Not listed
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsules (30-count unit dose packaging) with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract is classified as a non-set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $27,693.94 delivery order to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by June 13, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose 30-count supplies, with an ultimate completion date of August 22, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $41,540.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsules (30-count unit doses) on May 30, 2025, with completion scheduled for June 23, 2025. This is a non-set-aside competitive award, with performance to take place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $43,777.71 to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packages (30 count) on November 3, 2025, with completion expected by November 25, 2025. This is a firm fixed-price contract with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is a child order against the company's larger $999.9 billion...
- The Defense Logistics Agency awarded a delivery order valued at $14,592.57 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) to support federal medical procurement needs. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of November 19, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packages (30-count) on September 18, 2025, with completion scheduled for October 9, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Vyndamax 61 mg capsules in unit-dose packaging (30-count). The contract, with an ultimate completion date of August 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This competitively...
- The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsules (unit dose, 30-count packages) under a firm fixed price contract. The delivery order, awarded on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a non-set-aside competitive award. Performance will be executed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is a child contract awarded...
- The Defense Logistics Agency awarded a delivery order valued at $83,081.82 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This firm fixed price delivery order, which carries an ultimate completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCXGTDelivery Order
The Defense Logistics Agency has awarded a $13,846.97 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count), with a completion date of June 24, 2025. This competitively awarded, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The product will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company serves as a major pharmaceutical distributor and critical vendor for federal medical procurement needs. AmerisourceBergen Drug Corp leverages its comprehensive pharmaceutical supply agreement with the DLA to fulfill medical requirements across military and veteran healthcare systems. The company's SPE2DX contract vehicle encompasses a broad spectrum of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs globally. This delivery order for Vyndamax—a medication used in neurological treatment—exemplifies the company's role in supplying specialized medications through the DLA's flexible contracting mechanism, enabling efficient procurement of critical medical commodities for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 6/2/25 |